FerdinandMason

Partner

(T) + 44.20.7039.5724

As an M&A lawyer, Ferdinand Mason's substantial transaction experience and technical skill allow him to effectively manage complicated multijurisdictional transactions with an eye towards cultural and jurisdictional differences. Specifically, Ferdinand advises public and private companies and private equity houses on mergers and acquisitions, takeovers and takeover preparedness, sales of distressed companies and asset portfolios, joint ventures, corporate governance, and general corporate counseling. He has represented clients in the energy, finance, pharmaceutical, media, automotive, retail, technology, and manufacturing industries.

Ferdinand also has extensive experience advising companies, boards, and individual directors on a wide range of corporate governance matters and legal and regulatory responsibilities, including disclosure, directors' duties, and contentious public shareholder meetings.

He has been quoted in The Wall Street Journal, Bloomberg, Sunday Telegraph, Daily Telegraph, and The Financial Times on global M&A related developments.

The Financial Times ranked Ferdinand in the top 10 of "Innovative Lawyers in the UK and Europe in 2014" for his cross-border M&A approach.

He has lectured extensively on M&A and corporate governance topics at several notable law schools.

Experience

  • Cineworld Group completes asset monetization strategies in United States through cinema sale-leaseback transactionsJones Day advised UK headquartered, Cineworld Group PLC in connection with an asset monetization strategy in the United States involving a combined cash consideration of $556.3 million cinema sale-leaseback transactions to convert a substantial portion of Cineworld’s U.S. real estate holdings into cash to leverage its equity and optimize efficiency.
  • European government seeks to minimize risks to sovereign balance sheet as a consequence of BrexitJones Day is advising a European government on an innovative international treaty and corporate based strategy to minimize risks to its sovereign balance sheet as a consequence of Brexit.
  • Underwriter completes series of private placements by Kiadis Pharma totaling €72.6 millionJones Day acted as underwriters counsel in a series of successful placements of new shares in Euronext Amsterdam and Brussels listed Kiadis Pharma NV for a total of €72.6 million.
  • HighBrook Income Property Fund acquires GroothandelsgebouwenJones Day advised HighBrook Income Property Fund, LP in its acquisition of Groothandelsgebouwen NV, (GHG), the largest multi-tenanted property in the Netherlands.
  • Qatalyst Partners acts as financial advisor in attempted $47 billion sale of NXP to QualcommJones Day advised Qatalyst Partners, the financial advisor to NXP Semiconductors N.V., in the attempted $47 billion sale of NXP to Qualcomm.
  • Global City Holdings sells Nova Królikarnia project to Ronson EuropeJones Day advised Global City Holdings B.V. ("GCH") in the sale of shares project companies owning properties constituting the Nova Królikarnia project in Warsaw and the loans granted by Global City Holdings B.V. to those project companies.
  • L1 Retail acquired Holland & Barrett from The Nature's Bounty Co. and The Carlyle Group for £1.77 billion (US$2.25 billion)Jones Day advised L1 Retail, the retail investment arm of LetterOne, on its acquisition of Holland & Barrett, Europe's largest health and wellness retailer, from The Nature's Bounty Co. and The Carlyle Group for £1.77 billion (US$2.25 billion).
  • Euronext attempts to acquire LCH.Clearnet SAJones Day advised Euronext N.V. in its attempted €510 million (US$530 million) all-cash offer to LCH.Clearnet Group Limited and London Stock Exchange Group plc to acquire LCH.Clearnet SA, a leading EMIR-authorized central counterparty serving Euronext's markets, pan-European electronic trading platforms, and OTC markets, which is headquartered in Paris with branches in Amsterdam and Brussels, as well as a representative office in Porto.
  • Euronext-listed company migrates to United KingdomJones Day is advising a Euronext-listed company on its corporate migration into the United Kingdom to safeguard its U.S. and UK operations from possible adverse Brexit consequences.
  • Reynolds American sells Natural American Spirit International businesses to JT Group for $5 billionJones Day advised Reynolds American Inc. in its $5 billion sale of the international rights to the Natural American Spirit brand name and associated trademarks, along with the international companies that distribute and market the brand outside the U.S., to the Japan Tobacco Group of companies (JT Group).
  • Global City Holdings launches $265 million stock repurchaseJones Day advised Global City Holdings N.V. ("GCH"), a public limited liability company listed on the Warsaw Stock Exchange, on the launch of its PLN 990,698,853 (approximately €237.7 million/ US$265.4 million) buy back offer to repurchase the GCH shares held by minority shareholders.
  • Crowne Group acquires Vari-Form from Sun Capital PartnersJones Day represented Crowne Group LLC, a leading manufacturer and distributor of both aftermarket and original equipment manufacturer component parts for the automotive and other industrial equipment markets, in connection with the acquisition and related financing of Vari-Form, Inc., a manufacturer of lightweight, hydroformed structural parts, from Sun Capital Partners.
  • Expropriated SNS Reaal bondholders challenge legality of taking and seek compensation from Dutch StateJones Day represents bondholders in connection with the Dutch State's nationalization of SNS Reaal NV and SNS Bank NV on February 1, 2013.
  • Liquidators seek advice in relation to dissolution of BVI limited partnershipJones Day is acting as lead advisers to Kenneth Krys and John Greenwood of KRyS Global in their capacity as joint dissolution trustees of Value Discovery Partners L.P. ("VDP"), a very substantial private equity fund.
  • Poland's Cinema City International sells movie theater business to Cineworld for £272 million (US$451 million)Jones Day advised the Board of Cinema City International NV ("CCI") in the sale of its movie theater business to British cinema operator Cineworld Group for £272 million (US$451 million) in cash.
  • AMS-IX advised in creating corporate and operational structure to launch U.S. AMX-IX Internet exchangeJones Day advised AMS-IX BV in creating a corporate and operational structure to launch AMS-IX Internet exchange in the U.S.
  • Tokyo Electron attempts $29 billion merger of equals with Applied MaterialsJones Day represented Tokyo Electron Limited in its proposed $29 billion merger of equals with Applied Materials, Inc., which, if completed, would have created a global innovator in semiconductor and display manufacturing technology based in The Netherlands and dual listed on NASDAQ and the Tokyo Stock Exchange.
  • Mitsui Chemicals acquires Heraeus Dental for €450 million (US$578 million)Jones Day advised Mitsui Chemicals, Inc. in its acquisition of the dental business of Heraeus Holding GmbH for €450 million (US$578 million).
  • Allen & Company advised OCI NV on $1 billion investment from Cascade Investment and others in support of its offer for Orascom ConstructionJones Day advised Allen & Company, the financial advisor to OCI NV, a Dutch company, in the $1 billion investment from Cascade Investment, an entity wholly owned by Bill Gates, Southeastern Asset Management and Davis Selected Advisors, and others in support of its offer for Orascom Construction.
  • Indonesian SOE acquires energy interests in AsiaJones Day advised an Indonesian SOE on acquisitions of energy interests in Asia.
  • Speaking Engagements

    • October 1, 2015
      Drivers and Trends in Global M&A 2015: This Year's Exposition On How to Close Deals in a Turbulent Regulatory and Increasingly Protectionist World
    • June 3, 2015
      Global Insights: The Future of M&A
    • May 4, 2015
      JDialog: How to Cross the Atlantic – U.S./German M&A
    • March 27, 2014
      Global Insights: The Future of M&A
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.